Reuters logo
BUZZ-NewLink Genetics Corp: Enters worldwide licensing deal with Roche
October 20, 2014 / 12:03 PM / 3 years ago

BUZZ-NewLink Genetics Corp: Enters worldwide licensing deal with Roche

** Drugmaker’s shares up nearly 29 pct at $37.80 premarket

** Company says it entered into worldwide license agreement with Roche Holding AG to develop NewLink’s cancer therapy

** Deal makes NewLink eligible to receive more than $1 billion in milestone payments

** NewLink, which holds a commercial license for an Ebola vaccine developed by the Canadian government, will receive an upfront payment of $150 million under the deal from Genentech, a member of the Roche Group

** Up to Friday’s close, NewLink’s shares had risen more than 33 pct this year

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below